Company Performance Metrics
Wilbur R. Leopold III: Co-founder and Vice President, Quality Assurance, Senior Oncology Fellow
MI Bioresearch is a specialty contract research organization (CRO) providing in vivo preclinical imaging services. With a proven track record of imaging and drug discovery expertise, the company enhances preclinical and translational research through its in vivo pharmaco-IMAGING platform. This combination of traditional pharmacology and innovative
imaging includes MRI, micro-CT, micro-PET, SPECT and optical (bioluminescence and fluorescence molecular tomography) tools to quantitatively measure the response to therapy at anatomical, functional and molecular levels. Molecular Imaging also provides supportive in vitro services.
They have performed over 2000 cell line based traditional oncology studies and over 500 imaging enhanced studies since their founding in 2003.
